CRISPR Therapeutics AG
Closed
SectorHealthcare
59.05 4.81
Overview
Share price change
24h
Min
55.99
Max
56.94
Income | -91M -214M |
|---|---|
Sales | 8.7M 10M |
EPS | -0.94 |
Profit margin | -2,102.79 |
Employees | 393 |
EBITDA | 7.3M -110M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +30.1% upside |
Next Earnings | 9 Nov 2026 |
|---|
Market Cap | 519M 5.1B |
|---|---|
Previous open | 54.24 |
Previous close | 59.05 |
News Sentiment
By Acuity
26%
74%
28 / 339 Healthcare
CRISPR Therapeutics AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
CRISPR Therapeutics AG Forecast
Price Target
By TipRanks
12 Months Forecast
Average 73.583 USD 30.1%
High 110 USD
Low 45 USD
Based on 13 Wall Street analysts offering 12 month price targets forCRISPR Therapeutics AG - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$